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PURE Shakes Up Nutritional Field: 
Finds High Fat Intake Beneficial 
The PURE study of dietary habits in 135,000 
people around the world is set to shake up the 
nutrition field, with results showing high fat 
intake—including saturated fat—was associated 
with a reduced risk of mortality 
PURE - Prospective Urban and Rural 
Epidemiological Study  
US MLE STEP 2 TEST 
A 54-year-old man with extensive, severe atherosclerosis 
sustains a thrombotic occlusion of the celiac trunk. The 
organs that receive their blood supply from this artery 
continue to function normally. Anastomoses between which 
of the following pairs of arteries would explain this 
phenomenon? 
(A) Left gastric artery and right gastric artery, (B) Left 
gastroepiploic artery and right gastroepiploic artery, 
(C) Proper hepatic artery and gastroduodenal artery, 
(D) Right colic artery and middle colic artery, (E) Superior 
pancreaticoduodenal artery and inferior 
pancreaticoduodenal artery 
https://www.mommd.com/usmle1to10.shtml 
US MLE STEP 2 EXPLANATION 
The correct answer is E. The superior pancreaticoduodenal 
artery is a branch of the gastroduodenal artery, which is a 
branch of the common hepatic artery, itself a branch of the 
celiac trunk. The inferior pancreaticoduodenal artery is a 
branch of the superior mesenteric artery. Occlusion of the 
celiac trunk would allow blood from the superior 
mesenteric artery to reach the branches of the celiac trunk 
via the connections between the superior and inferior 
pancreaticoduodenal arteries. 
https://www.mommd.com/usmle1to10.shtml 
Plan of the Lecture   
• Definition 
• Epidemiology 
• Risk factors 
• Etiology 
• Mechanisms  
• Classification 
• Clinical investigation 
• Diagnosis 
• Treatment  
• Prognosis 
• Prophylaxis 
• Abbreviations  
• Guidelines 
juventasclinic.com/wp-content/uploads/2014/03/cardiac-regenerative-therapy-2.png 
Definition  
Atherosclerosis ( arteriosclerotic vascular disease – 
ASVD, arteriosclerotic cardiovascular disease – 
ASCVD) is a disease affecting arterial blood 
vessels due to a chronic inflammatory response on 
cholesterol depositions  within their walls by the 
formation of multiple atheromatous plaques  and  
vascular lumens narrowing with manifestation 
in  numerous clinical syndromes from sudden 
cardiovascular death, acute heart and brain attacks, 
cognitive decline and dementia, heart and renal 
failure up to peripheral artery disease 
 en.wikipedia.org/wiki/Atherosclerosis 
Epidemiology    
(Focus on Key Points 1) 
• ASVD is a rising epidemic with severe health 
and economic consequences for all world 
regions, affecting men and women 
• ASVD is the leading cause of death worldwide 
resulting in 17 million deaths per year 
• ASVD begins early in life, and is a chronically 
progressive disorder that is initiated and 
progressively advanced by specific lifestyle 
conditions and genetic factors  
casinapioiv.va/content/dam/accademia/pdf/atherosclerosis.pdf 
Epidemiology    
(Focus on Key Points 2) 
 
•  ASVD disease worsens exponentially with 
increasing age and the burden of 
atherosclerotic disease is expected to double 
by 2030 as the population ages  
casinapioiv.va/content/dam/accademia/pdf/atherosclerosis.pdf 
Epidemiology   
(Prevalence of ASVD by Race) 
indiana.edu/~k562/images/athero/atherorace.jpg 
Risk Factors 
(Modifiable 1) 
en.wikipedia.org/wiki/Atherosclerosis 
• Diabetes or impaired glucose tolerance (IGT)   
• Dyslipoproteinemia: high serum concentration 
of low-density lipoprotein (LDL), and / or very 
low density lipoprotein (VLDL) particles; low 
serum concentration of functioning high 
density lipoprotein (HDL); an LDL:HDL ratio 
greater than 3:1 
• Tobacco smoking  
• Overweight and Obesity  
Risk Factors 
(Modifiable 1) 
en.wikipedia.org/wiki/Atherosclerosis 
• Physical inactivity 
• Elevated serum C-reactive 
protein concentrations 
• Hypertension 
• Vitamin B6 deficiency 
• Dietary iodine deficiency and hypothyroidism  
Risk Factors 
(Nonmodifiable) 
en.wikipedia.org/wiki/Atherosclerosis 
• Advanced age 
• Male sex 
• Having close relatives who have had some 
complication of atherosclerosis (e.g. coronary 
heart disease or stroke) 
• Genetic abnormalities, e.g. familial 
hypercholesterolemia 
Risk Factors 
(Lesser or Uncertain 1) 
en.wikipedia.org/wiki/Atherosclerosis 
• Being of South Asian ethnicity   
• Hypercoagulability 
• Postmenopausal estrogen deficiency 
• High intake of saturated fat 
• Trans fat intake  
• High carbohydrate intake 
• Elevated serum levels of triglycerides 
• Elevated serum levels of homocysteine  
Risk Factors 
(Lesser or Uncertain 2) 
en.wikipedia.org/wiki/Atherosclerosis 
•  Elevated serum levels of uric acid  
• Elevated serum fibrinogen concentrations 
• Elevated serum lipoprotein concentrations 
• Chronic systemic inflammation  
• Elevated serum insulin levels  
• Short sleep duration 
• Chlamydia pneumoniae infection 
• Air pollution 
Risk Factors 
(Total Cardiovascular Risk 1) 
escardio.org/static_file/Escardio/Guidelines/publications/DYSLIPguidelines-dyslipidemias-FT.pdf 
All guidelines recommend the assessment of 
Total Cardiovascular Risk because, in most 
people, ASVD is the product of a number of risk 
factors. Many risk assessment systems are 
available, including Framingham, SCORE 
(Systemic Coronary Risk Estimation),  etc.   
Very simple principles of risk SCORE ‘ 
assessment can be defined as follows  
Risk Factors 
(Total Cardiovascular Risk 2) 
escardio.org/static_file/Escardio/Guidelines/publications/DYSLIPguidelines-dyslipidemias-FT.pdf 
•  Those with known cardiovascular disease 
(CVD), type 2 diabetes or type 1 diabetes with 
microalbuminuria, very high levels of 
individual risk factors, chronic kidney disease 
(CKD) are automatically at very high or high 
total cardiovascular risk and need active 
management of all risk factors  
Risk Factors 
(Total Cardiovascular Risk 3) 
escardio.org/static_file/Escardio/Guidelines/publications/DYSLIPguidelines-dyslipidemias-FT.pdf 
• For all other people, the use of a risk 
estimation system such as Systemic Coronary 
Risk Estimation (SCORE) is recommended to 
estimate total cardiovascular risk (CV) risk 
because many people have several risk factors 
which, in combination, may result in 
unexpectedly high levels of total 
cardiovascular risk 
Risk Factors 
(Total Cardiovascular Risk 1) 
escardio.org/static_file/Escardio/Guidelines/publications/DYSLIPguidelines-dyslipidemias-FT.pdf 
• SCORE is 
intended to 
facilitate risk 
estimation in 
apparently 
healthy persons 
with no signs of 
clinical or pre-
clinical disease  
Risk Factors 
(Total Cardiovascular Risk 2) 
escardio.org/static_file/Escardio/Guidelines/publications/DYSLIPguidelines-dyslipidemias-FT.pdf 
• Patients who have had 
a clinical event such as 
an acute coronary 
syndrome (ACS) or 
stroke are at high risk 
of a further event and 
automatically qualify 
for intensive risk factor 
evaluation and 
management 
Etiology     
(Genetic and Acquired Factors) 
• The etiology of ASVD is 
unknown, but there are 
multiple factors that 
contribute to 
atherosclerotic plaque 
progression 
• These include genetic 
and acquired factors 
content.onlinejacc.org/article.aspx?articleid=1124505 
Interactive Role of Infection, 
Inflammation and Traditional Risk Factors 
in Atherosclerosis 
 
Mechanisms   
(Key Moments 1)     
 en.wikipedia.org/wiki/Atherosclerosis 
• Laying in the base of ASVD atherogenesis is the 
process of atheromatous plaques formation due 
to disturbed lipid  metabolism (dyslipidemia) 
that is characterized by subendothelial 
accumulation of abnormal fatty substances with 
inflammatory response   
• The buildup of an atheromatous plaques is a 
slow process, developed over a period of 
several years  
Mechanisms   
(Key Moments 2)     
 en.wikipedia.org/wiki/Atherosclerosis 
• At first, as the plaques grow, only wall 
thickening occurs without any narrowing 
• Stenosis is a late event, which may never occur 
and is often the result of repeated plaque 
rupture and healing responses, not just the 
atherosclerotic process by itself 
Mechanisms   
(Passions around Dyslipidemia 1)     
escardio.org/static_file/Escardio/Guidelines/publications/DYSLIPguidelines-dyslipidemias-FT.pdf 
• Dyslipidemia can be developed in different ways 
and by itself and through interaction with other 
cardiovascular risk factors may affect the 
development of ASVD 
• Dyslipidemia may be related to other diseases 
(secondary) or to the interaction between 
genetic predisposition and environmental 
factors and cover a broad spectrum of lipid 
abnormalities, some of which are of great 
importance in ASVD prevention  
Mechanisms   
(Passions around Dyslipidemia 2)     
escardio.org/static_file/Escardio/Guidelines/publications/DYSLIPguidelines-dyslipidemias-FT.pdf 
• A particular pattern of dyslipidemia, termed the 
atherogenic lipid triad, is more common than 
others, and consists of the co-existence of 
increased very low density lipoprotein (VLDL) 
remnants manifested as mildly elevated 
triglycerides (TG), increased small dense low-
density lipoprotein (LDL) particles, and reduced 
high density lipoprotein (HDL) levels  
Mechanisms   
(Progression of Atherosclerosis 1)      
 reference.medscape.com/article/1612610-overview#a3 
• Processes involved 
in atherosclerosis 
include 
coagulation, 
inflammation, lipid 
metabolism, 
intimal injury, and 
smooth muscle cell 
proliferation   
Mechanisms   
(Progression of Atherosclerosis 2)      
 reference.medscape.com/article/1612610-overview#a3 
• Early lesion 
development is 
marked by lipid 
retention with 
activation of 
endothelial 
adhesion 
molecules  
Mechanisms   
(Progression of Atherosclerosis 2)      
 reference.medscape.com/article/1612610-overview#a3 
• Inflammatory 
macrophages play a 
significant role 
throughout all phases of 
atherosclerotic 
progression; 
hyperlipidemia-induced 
macrophage infiltration 
of the arterial intima is 
one of the earliest 
pathologic changes 
Mechanisms   
(Pathways in Evolution and Progression of 
Atherosclerotic Lesions)     
 circ.ahajournals.org/content/92/5/1355/F5.expansion.html 
• Roman numerals indicate 
histologically characteristic 
types of lesions  
• The direction of arrows 
indicates sequence in which 
characteristic morphologies 
may change 
• From type I to type IV, 
changes in lesion 
morphology occur primarily 
because of increasing 
accumulation of lipid 
• The loop between types V 
and VI illustrates how 
lesions increase in thickness 
when thrombotic deposits 
form on their surfaces 
• Thrombotic deposits may 
form repeatedly over varied 
time spans in the same 
location and may be the 
principal mechanism for 
gradual occlusion of 
medium-sized arteries 
Mechanisms   
(Schematic Presentation of Evolution and 
Progression of Atherosclerotic Lesions)     
upload.wikimedia.org/wikipedia/commons/9/9a/Endo_dysfunction_Athero.PNG 
US MLE STEP 2 TEST 
A 65-year-old Caucasian male presents to the emergency 
room with chest pain. Coronary angiography reveals 
significant stenosis of the left anterior descending (LAD) 
artery. Which of the following characteristics of the atheroma 
is the most important physiologically plausible predictor of 
myocardial necrosis in this patient? 
A. Cholesterol crystal presence, B. Rate of formation, C. 
Calcium content, D. Presence of cytokines, E. Amount of foam 
cells  
https://www.mommd.com/usmle1to10.shtml 
US MLE STEP 2 EXPLANATION 
• The most important factor as to whether or not a coronary 
artery plaque will cause an ischemic myocardial infarction 
(MI), is the rate in which the artery is occluded 
• A slow-forming atheroma allows for formation of collateral 
circulation, thereby lowering the chance of MI and necrosis 
• With rapid coronary occlusion, there is not enough time for 
collateral development and thus myocardial ischemia is 
inevitable   
https://www.mommd.com/usmle1to10.shtml 
Classification 
(Modified AHA Consensus Classification Based on 
Morphologic Descriptions:Nonatherosclerotic intimal 
lesions) 
 reference.medscape.com/medline/abstract/10807742 
Morphology Description Thrombosis 
Intimal 
thickening 
Normal accumulation of smooth 
muscle cells (SMCs) in the intima 
in the absence of lipid or 
macrophage foam cells 
Absent 
Intimal 
xanthoma 
Superficial accumulation of foam 
cells without a necrotic core or 
fibrous cap; based on animal and 
human data, such lesions usually 
regress 
Absent 
Classification 
(Modified AHA Consensus Classification Based on 
Morphologic Descriptions: Progressive 
atherosclerotic lesions) 
 reference.medscape.com/medline/abstract/10807742 
Morphology Description 
Throm-
bosis 
Pathologic 
intimal 
thickening 
SMC-rich plaque with proteoglycan 
matrix and focal accumulation of 
extracellular lipid 
Absent 
Fibrous cap 
atheroma 
Early necrosis  
Late necrosis  
Absent 
Thin cap 
fibroatheroma 
A thin, fibrous cap infiltrated by 
macrophages and lymphocytes 
with rare or absence of SMCs   
Absent 
Classification 
(Modified AHA Consensus Classification Based on 
Morphologic Descriptions: Lesions with acute 
thrombi) 
 reference.medscape.com/medline/abstract/10807742 
 
 
Description Thrombosis 
Plaque 
rupture 
Fibroatheroma with fibrous 
cap disruption  
Occlusive or 
nonocclusive 
Plaque 
erosion 
Plaque composition, as above  
Usually 
nonocclusive 
Calcified 
nodule 
Eruptive (shedding) of 
calcified nodules   
Usually 
nonocclusive 
Classification 
(Modified AHA Consensus Classification Based on 
Morphologic Descriptions: Lesions with healed 
thrombi) 
 reference.medscape.com/medline/abstract/10807742 
Morphology Description Thrombosis 
Fibrotic 
(without 
calcification)Fib
rocalcific (+/- 
necrotic core) 
Collagen-rich plaque with 
significant luminal stenosis 
these lesions may 
represent healed erosions 
or ruptures 
Absent 
Classification 
(Frederic Classification of Lipid Disorders) 
gpnotebook.co.uk/simplepage.cfm?ID=x20020617063512021840 
LDL - low-density lipoproteins; C - total cholesterol; TG 
- triglycerides; VLDL - very low-density lipoproteins 
Classification 
(International Classification of Diseases (ICD) 1) 
google.com.ua/webhp?sourceid=chrome-instant&ion=1&espv=2&ie=UTF-8#q=international%20diseases%20classification%2010 
Chapter V 
(F00-F99) Mental and behavioral disorders 
 F00-F09 Organic, including symptomatic, mental 
disorders 
Chapter IX 
(I00-I99) Diseases of the circulatory system 
 I20-I25 Ischaemic heart diseases 
 (I60-I69) Cerebrovascular diseases 
 I70-I79 Diseases of arteries, arterioles and 
capillaries    
Classification 
(International Classification of Diseases (ICD) 1) 
google.com.ua/webhp?sourceid=chrome-instant&ion=1&espv=2&ie=UTF-8#q=international%20diseases%20classification%2010 
   
 170       Atherosclerosis 
  I70.0  Atherosclerosis of aorta 
  I70.1  Atherosclerosis of renal artery  
  I70.2  Atherosclerosis of arteries of 
extremities  
  I70.8  Atherosclerosis of other arteries 
  I70.9  Generalized and unspecified 
atherosclerosis 
 
   
 
Classification 
(Overlap of Atherosclerotic Disease) 
healthline.com/health/atherosclerosis#Types2 thelancet.com/cms/attachment/2001932257/2006685340/gr1.jpg 
• Coronary artery 
disease 
• Carotid artery 
disease 
• Peripheral artery 
disease 
• Kidney disease 
 Patients with one type of 
ASVD are also at risk of 
having other types 
Clinical Investigation  
(Passions around Symptoms 1) 
• ASVD is asymptomatic for decades, even 
most plaque ruptures do not produce symptoms 
until enough narrowing or closure of an artery, due 
to clots, occurs 
• Symptomatic ASVD is typically associated with men 
in their 40s and women in their 50s to 60s  
en.wikipedia.org/wiki/Atherosclerosis 
Clinical Investigation  
(Passions around Symptoms 2) 
• Signs and symptoms only occur after severe 
narrowing or closure impedes blood flow to 
different organs enough to induce symptoms and 
most of the time, patients realize that they have the 
disease   
• Clinical manifestation and picture of ASVD strictly 
depends from a level and  severity lesions of 
systemic circulation arteries, more often aorta, 
coronary, carotid, iliac, femoral, renal, etc.  
en.wikipedia.org/wiki/Atherosclerosis 
Clinical Investigation  
(Modalities of Symptoms 1) 
• ASVD causes symptoms by arterial obstruction, 
embolization of plaque material, and weakening 
with rupture of the arterial wall 
• Obstruction with or without embolization causes 
ischemia of the circulation supplied by the vessel: 
• Ischemic strokes result from ASVD of the carotid 
arteries and aortic arch, which embolize thrombi 
and atherosclerotic material, as well as local 
atherosclerosis of the cerebral vessels   
 reference.medscape.com/article/1612610-overview#a5 
Clinical Investigation  
(Modalities of Symptoms 2) 
–Obstruction of coronary arteries causes 
myocardial ischemia that may present as acute 
coronary syndromes, sudden death, or 
chronic congestive heart failure 
–Obstruction of iliac vessels results in ischemia of 
the lower extremities (claudication) 
–Atherosclerotic aneurysms  show a predilection 
for the aorta, especially the abdominal aorta, 
that may rupture and cause death by 
hemorrhage 
 reference.medscape.com/article/1612610-overview#a5 
Clinical Investigation  
(Involved Organs’ Symptoms 1) 
• Heart - chest pain of angina and shortness of 
breath, sweating, nausea, dizziness or light-
headedness, breathlessness or palpitations 
• Brain - dizziness or confusion; weakness or paralysis 
on one side of the body; sudden, severe numbness 
in any part of the body; visual disturbance, 
including sudden loss of vision; difficulty walking, 
including staggering or veering; coordination 
problems in the arms and hands; and slurred 
speech or inability to speak   
drugs.com/health-guide/atherosclerosis.html 
Clinical Investigation  
(Involved Organs’ Symptoms 2) 
• Abdomen - dull or cramping pain in the middle of 
the abdomen, usually beginning 15 to 30 minutes 
after a meal  
• Legs - cramping pain in the leg muscles, especially 
during exercise; if narrowing is severe, there may be 
pain at rest, cold toes and feet, pale or bluish skin 
and hair loss on the legs 
drugs.com/health-guide/atherosclerosis.html 
Clinical Investigation  
(Physical Examination 1) 
• A weak or absent pulse below the narrowed area of 
affected artery 
• Decreased blood pressure in an affected limb 
• Whooshing sounds (bruits) over affected arteries  
• Weak pulses 
• Cool skin that is pale or blue in an affected limb 
• Hair loss on an affected limb 
• Male erectile dysfunction 
eurheartj.oxfordjournals.org/content/ehj/34/28/2159.full.pdf 
Clinical Investigation  
(Physical Examination 2) 
• Numbness in an affected limb 
• The toenails get thicker 
• Weakness in an affected limb 
• Early gray hair 
• Reduced skin turgor 
• Xanthomas and xanthelasma 
• Senile corneal arc 
• Abundant growth of hair on the ears 
• Vertical or diagonal crease in the earlobe 
eurheartj.oxfordjournals.org/content/ehj/34/28/2159.full.pdf 
Clinical Investigation  
(Xanthoma) 
annalspc.com/article.asp?issn=0974-2069;year=2014;volume=7;issue=2;spage=118;epage=119;aulast=Moorthy 
A 19-year-old male presented with 
effort angina of 6-month duration, 
which has worsened since 1 month 
associated with rest angina, and 
postprandial angina.   Extensive 
xanthoma tuberosum around 
shoulders, elbows, wrists, and sacrum  
Clinical Investigation  
(Xanthelasma) 
emedicine.medscape.com/article/1213423-overview 
Xanthelasma of four eyelids in 
patient with hyperlipidemia. 
Xanthelasma can be soft, 
semisolid, or calcareous. 
Frequently, they are 
symmetrical. The upper lids are 
more frequently involved than 
the lower lids. Xanthelasma 
have a tendency to progress, 
coalesce, and become 
permanent  
Clinical Investigation  
(Vertical or diagonal crease in the earlobe) 
vivajoyhealth.blogspot.com/ 
Hairs protruding out of the ear-tube and crease 
on the ear lobe have significant correlation with 
higher incidence of coronary risk 
Clinical Investigation  
(Outcomes 1) 
• Premature death   
• Thrombosis 
• Vascular aneurisms 
•  Severe vascular narrowing 
• Vascular ruptures and hemorrhages  
• Acute ischemic vascular syndromes  
jpkc.gdmc.edu.cn/blx/10jxwz/tupu/bltp/8xxg10.htm 
Clinical Investigation  
(Outcomes 2) 
• Chronic multiple organ dysfunction and failure 
(cognitive impairment and dementia, chronic 
heart failure, chronic kidney disease, limb 
gangrene)   
• Premature aging 
• Etc.  
jpkc.gdmc.edu.cn/blx/10jxwz/tupu/bltp/8xxg10.htm 
Clinical Investigation  
(Thrombosis) 
This cross section reveals a 
large myocardial infarction 
involving the anterior left 
ventricular wall and septum. 
Here is the coronary 
thrombosis at higher 
magnification. The thrombus 
occludes the lumen and 
produces ischemia 
jpkc.gdmc.edu.cn/blx/10jxwz/tupu/bltp/8xxg10.htm 
Clinical Investigation  
(Vascular aneurisms 1) 
• Different types of (aortic) 
aneurysm  
• An aneurysm is a bulging, 
weakened area in the wall of a 
blood vessel resulting in an 
abnormal widening or ballooning 
greater than 50% of the vessel's 
normal diameter (width)  
hopkinsmedicine.org/healthlibrary/conditions/cardiovascular_diseases/aneurysm_85,p00193/ 
Clinical Investigation  
(Vascular aneurisms 2) 
•   
• An aneurysm may occur in any 
blood vessel, but is most often seen 
in an artery rather than a vein 
hopkinsmedicine.org/healthlibrary/conditions/cardiovascular_diseases/aneurysm_85,p00193/ 
Clinical Investigation  
(Vascular aneurisms) 
Basilar tip aneurysms are usually diagnosed after a 
subarachnoid hemorrhage or workup for cranial nerve 
dysfunction.  Non-contrasted head CT scans can 
illustrate blood in the subarachnoid space if the 
aneurysm has ruptured. 
virtualmedstudent.com/links/neurological/aneurysm_basilar_artery.html 
Clinical Investigation  
(Severe vascular narrowing) 
Computed Tomography Angiography (CCTA). The 
3 main types of coronary plaques: calcified (A, D), 
non-calcified (B, E) and partially calcified plaques 
(C, F), illustrated in curved planar reformatted 
and cross-sectional views. 
ntechopen.com/books/coronary-artery-disease-assessment-surgery-prevention/coronary-ct-angiography-and-the-napkin-ring-sign-indicates-high-risk-atherosclerotic-lesions 
US MLE STEP 2 TEST 
In which of the following locations would you least  
expect to find significant atherosclerotic lesions in a patient  
with risk factors of smoking, hypertension, diabetes mellitus, 
and serum cholesterol level of 280 mg/dL?  
A) Left main coronary artery, B) Aortic bifurcation, C) Circle of 
Willis, D) Pulmonary artery trunk , E) Common carotid artery 
https://www.mommd.com/usmle1to10.shtml 
US MLE STEP 2 EXPLANATION 
Frequency in descending order of most commonly involved 
arteries   
 
1. Lower abdominal aorta (abdominal > thoracic, high assoc. 
with smoking, no vasa vasorum below renal arteries) 
2. Coronary arteries (also cerebrovascular arteries) 
3. Popliteal arteries (lower extremity arteries) 
4. Internal carotid arteries 
5. Vessels in the circle of Willis 
http://cueflash.com/decks/Atherosclerosis_-_Path 
Clinical Investigation  
(Severe vascular narrowing) 
CT angiography images (a and b) showing critical stenosis at 
the left ICA origin. Localization of level of stenotic ICA in 
relation to the cervical spine bony anatomical landmarks on 
imaging to plan optimum level of exposure (c). A preoperative 
MRI T2-axial image (d) showing evidence of subcortical and 
deep white matter ischemic lesions. A postoperative MR 
angiography (e and f) showing complete restoration of normal 
ICA caliber. 
neurologyindia.com/article.asp?issn=0028-3886;year=2011;volume=59;issue=3;spage=390;epage=396;aulast=Misra;type=3 
Clinical Investigation  
(Severe vascular narrowing) 
• Severe atherosclerosis of 
cerebral arteries 
• Atheromatous plaques may 
cause narrowing or occlusion of 
the vascular lumen by 
themselves or after rupture and 
thrombosis 
•  Cholesterol crystals from 
ruptured plaques may embolize 
neuropathology-web.org/chapter2/chapter2bCerebralinfarcts.html 
Clinical Investigation  
(Severe vascular narrowing) 
An ischemic ulcer is characterized by a gangrenous 
skin change in the foot or toes. The foot is usually cold 
to touch with absent pedal pulses. The foot is painful 
to touch with decreased distal capillary refills. 
aneskey.com/extremity-conditions 
Clinical Investigation  
(Vascular ruptures and hemorrhages) 
Classification of aortic dissection localization  
eurheartj.oxfordjournals.org/content/35/41/2873 
Clinical Investigation  
(Vascular ruptures and hemorrhages) 
 Hemorrhagic infarcts are most common in embolism. 
Use of thrombolytics or anticoagulants may convert a 
bland infarct into a hemorrhagic one. 
neuropathology-web.org/chapter2/chapter2bCerebralinfarcts.html 
Clinical Investigation  
(Limb gangrene) 
Dry gangrene of the toes showing the areas of total 
tissue death, appearing as black and lighter shades of 
discoloration of the skin demarcating areas of 
impending gangrene. (Photo contributor: Lawrence B. 
Stack, MD.) 
aneskey.com/extremity-conditions 
Diagnosis 1 
  
• Blood tests: cholesterol and C-reactive protein 
levels, lipoproteinogram  
• B-mode, Doppler and intravascular 
ultrasound: degree of any blockages in 
arteries 
• Ankle-brachial index: recognition of peripheral 
vascular disease, which is usually caused by 
atherosclerosis 
• Electrocardiogram (ECG): reveal  evidence of a 
previous heart attacks  
mayoclinic.org/diseases-conditions/arteriosclerosis-atherosclerosis/diagnosis-treatment/diagnosis/dxc-20167050 
Diagnosis 2 
  
• Stress test (including 
echocardiogram): reveal  evidence of a chronic 
coronary artery disease 
•  Vascular catheterization and angiogram: 
reveal  evidence of narrowed, blocked or 
aneurismatic arteries 
• Other imaging tests (CT, MRA, etc.): 
reveal  evidence of narrowed or blocked 
arteries, as well as aneurysms and calcium 
deposits in the artery walls 
 
mayoclinic.org/diseases-conditions/arteriosclerosis-atherosclerosis/diagnosis-treatment/diagnosis/dxc-20167050 
Diagnosis 
(B-mode ultrasound) 
B-mode ultrasound imaging of the left carotid artery 
in a long-axis during a 10 years period follow-up 
(1998-2008) in a healthy man from 45 to 55 years of 
age.   
ntechopen.com/books/ultrasound-imaging-medical-applications/atherosclerotic-plaque-regression-and-arterial-reverse-remodelling-in-carotid-and-femoral-arteries-b 
Diagnosis 
(B-mode ultrasound) 
Normal intima-media thickness (IMT) appearance (top 
left), IMT measurement example (top right), fatty 
streak (bottom left), and a homogenous hyperechoic 
nonstenosing plaque (bottom right). 
radiologykey.com/the-role-of-ultrasound-in-the-management-of-cerebrovascular-disease/ 
Diagnosis 
(Doppler ultrasound) 
 The right internal carotid artery stenosis estimated 
between 50 - 69% 
radiopaedia.org/articles/ultrasound-assessment-of-carotid-arterial-atherosclerotic-disease 
Diagnosis 
(Intravascular ultrasound) 
Intravascular ultrasound image of a coronary artery 
(left), with color-coding on the right, delineating the 
lumen (yellow), external elastic membrane (blue) and 
the atherosclerotic plaque burden (green).  As the 
plaque burden increases, the lumen size will decrease 
and the degree of stenosis will increase. 
en.wikipedia.org/wiki/Intravascular_ultrasound 
Diagnosis 
(Combine visualization 1) 
Example of the terminal 
vertebral stenosis as shown in 
the upper left insert of images 
(large arrow, stenosis on 
arteriogram). On the upper 
right insert, bilateral terminal 
vertebral artery (VA) occlusions 
with reversal of the basilar 
artery (BA) flow.   
radiologykey.com/the-role-of-ultrasound-in-the-management-of-cerebrovascular-disease/ 
Diagnosis 
(Combine visualization 1) 
The lower inserts show a high-
grade proximal VA stenosis 
with a high-resistance 
(arrow) preobstructive 
flow (left image) and a velocity 
jet (double arrows) across the 
lesion (right image). EDV, end-
diastolic velocity; PSV, peak 
systolic velocity. 
radiologykey.com/the-role-of-ultrasound-in-the-management-of-cerebrovascular-disease/ 
Diagnosis 
(Ankle-brachial index) 
  
intranet.tdmu.edu.ua/data/kafedra/internal/surgery2/classes_stud/en/med/lik/ptn/surgery/5/Topic%2008.%20Arteries%20occlusive%20diseases.Mesenteric%20artery%20diseases.htm 
Diagnosis 
(Electrocardiogram)  
An old post-infarction scar of the front wall (deep Q in 
V1- V4).  ST sections for QRS in V1 -V4 are elevated, 
best seen in V4 where the elevation reminds the 
Pardee’s wave (underlined in red). 
health-tutor.com/myocardial-scar-ecg.html 
Diagnosis 
(Vascular catheterization and angiogram) 
  
intranet.tdmu.edu.ua/data/kafedra/internal/surgery2/classes_stud/en/med/lik/ptn/surgery/5/Topic%2008.%20Arteries%20occlusive%20diseases.Mesenteric%20artery%20diseases.htm 
A multidetector computed 
tomographic angiogram with three-
dimensional reconstruction of the 
iliofemoral arterial circulation. An 
occluded right superficial femoral 
artery (single long arrow) with 
reconstituted superficial femoral 
artery at the level of midthigh. Arterial 
calcifications (short arrows) in the 
bilateral distal superficial femoral 
arteries. 
Diagnosis 
(Vascular catheterization and angiogram) 
  
intranet.tdmu.edu.ua/data/kafedra/internal/surgery2/classes_stud/en/med/lik/ptn/surgery/5/Topic%2008.%20Arteries%20occlusive%20diseases.Mesenteric%20artery%20diseases.htm 
Three-dimensional computed tomographic angiogram 
of an abdominal aortic aneurysm that displays various 
aneurysm components, including thrombus, aortic 
calcification, blood circulation, and aneurysm wall. 
Diagnosis 
(Vascular catheterization and angiogram) 
  
intranet.tdmu.edu.ua/data/kafedra/internal/surgery2/classes_stud/en/med/lik/ptn/surgery/5/Topic%2008.%20Arteries%20occlusive%20diseases.Mesenteric%20artery%20diseases.htm 
 Multidetector computed 
tomography (CT) angiography. 
Pertinent collateral pathways are 
developed in the event of chronic 
severe aortoiliac occlusive disease. 
The collaterals include epigastaric 
arteries (large white arrows), an 
enlarged inferior mesenteric artery 
(white arrowhead), and enlarged 
lumbar arteries (black arrows). 
Diagnosis 
(Vascular catheterization and angiogram) 
  
intranet.tdmu.edu.ua/data/kafedra/internal/surgery2/classes_stud/en/med/lik/ptn/surgery/5/Topic%2008.%20Arteries%20occlusive%20diseases.Mesenteric%20artery%20diseases.htm 
Multidetector computed 
tomography angiography of the 
aortoiliac artery circulation in a 63-
year-old man with buttock 
claudication. Three-dimensional 
image reconstruction showing 
intra-arterial calcification of the 
aorta (large arrows) and right 
common iliac artery (small 
arrows).  
Treatment 
(Key Points 1) 
• Acute and chronic treatment strategies for 
acute vascular events are proven to reduce 
disability/death but access to care is often 
lacking 
• Interventions to consider: the polypill 
approach for primary and secondary 
prevention is a cost-effective and evidence-
based  
casinapioiv.va/content/dam/accademia/pdf/atherosclerosis.pdf 
Treatment 
(Key Points 2) 
• Percutaneous interventions with stenting and 
surgeries (by-pass and endarterectomy) are 
effective measures for certain scenarios of 
coronary, cerebral and other artery stenosis 
and occlusions 
• The most cost-effective management of ASVD 
is one of an integrated treatment based on a 
Total Vascular Risk approach   
casinapioiv.va/content/dam/accademia/pdf/atherosclerosis.pdf 
Treatment 
(Percutaneous interventions with stenting 
and surgeries) 
(1) Progression of coronary artery disease. (A) Atherosclerosis 
plaque buildup in the artery and blood clot occluding blood 
fow; (B) stent compressing the plaque, with widening of the 
artery; (C) in-stent restenosis decreasing and occluding the 
blood flow. (2) Myocardial infarction highlighting a localized 
area of ischemia and dead heart muscle. 
researchgate.net/figure/235436182_fig2_1-Pathophysiological-presentations-and-progression-of-coronary-artery-disease-A 
Treatment 
(Lifestyle Changes) 
• Salt restriction  
• Moderation of alcohol consumption 
• Other dietary changes (vegetables, low-fat 
dairy products, dietary and soluble fibers, 
whole grains and protein from plant sources, 
reduced in saturated fat and cholesterol) 
• Weight reduction 
• Regular physical exercise 
• Smoking cessation  
 
emedicine.medscape.com/article/198475-overview#a3  
Treatment 
(Education 1) 
• There should be a change in focus in the 
education of all physicians to more strongly 
emphasize evidence based primary prevention 
of ASVD 
• Education focused on school children, 
especially targeted to create sustainable 
healthy behavior and sustainable control of risk 
factors  
casinapioiv.va/content/dam/accademia/pdf/atherosclerosis.pdf 
Treatment 
(Education 2) 
• Telemedicine has been proven effective in 
selected world regions 
• Engage the media to promote education for 
ASVD prevention, and the need for rapid access 
to treatment 
• Produce easily accessible (through medical 
journals and internet) guidelines for 
management of ASVD   
casinapioiv.va/content/dam/accademia/pdf/atherosclerosis.pdf 
Treatment 
(Pharmacotherapy 1) 
• Cholesterol medications (statins, fibrates, 
nicotinic acid (niacin), omega-3 
supplementation, bile acid sequestrants)   
• Anti-inflammatory medications (selective 
inhibition of Lp-PLA2 with darapladib ) 
• Anti-platelet medications (aspirin, clopidogrel, 
etc.) 
• Beta blocker medications (for coronary artery 
disease)  
mayoclinic.org/diseases-conditions/arteriosclerosis-atherosclerosis/diagnosis-treatment/treatment/txc-20167054 
Treatment 
(Pharmacotherapy 2) 
• Angiotensin-converting enzyme (ACE) inhibitors   
• Calcium channel blockers   
• Diuretics (for ASVD arterial hypertension) 
• Other medications (to control specific risk 
factors for atherosclerosis, such as diabetes)  
• Efferent therapy (enterosorption, 
hemadsorption, LDL hemadsorption) 
mayoclinic.org/diseases-conditions/arteriosclerosis-atherosclerosis/diagnosis-treatment/treatment/txc-20167054 
Treatment 
(Statins 1) 
• Statins or HMG-CoA reductase inhibitors, are a 
class of lipid-lowering 
medications that inhibit the enzyme HMG-CoA 
reductase which plays a central role in the 
production of cholesterol 
• Statins have been found to reduce ASVD 
disease and mortality in those who are at high 
risk  
en.wikipedia.org/wiki/Statin 
Treatment 
(Statins 2) 
• Side effects of statins include muscle pain, 
increased risk of diabetes mellitus, and 
abnormalities in liver enzyme tests 
• A number of statins are on the market: 
atorvastatin, fluvastatin, lovastatin, 
pitavastatin, pravastatin, 
rosuvastatin and simvastatin 
en.wikipedia.org/wiki/Statin 
Treatment 
(Statins) 
Major recommendations for statin therapy for ASCVD 
prevention 
circ.ahajournals.org/content/early/2013/11/11/01.cir.0000437738.63853.7a 
2013 ACC/AHA 
Prognosis 1  
• ASVD leads to the number one cause of death 
around the World for both men and women 
• However, people with ASVD are living longer 
with better quality of life than ever before 
• For many, this is disease can be prevented  
drugs.com/health-guide/atherosclerosis.html 
Prognosis 2  
 
• Even those people genetically programmed for 
atherosclerosis can delay the beginning and 
worsening of the disease with a healthy 
lifestyle, the right foods, and medication to 
lower LDL cholesterol 
drugs.com/health-guide/atherosclerosis.html 
Prophylaxis 1 
• Risk factor assessment and modification 
should begin early in life (childhood) 
• Most risk factors can be modified by lifestyle 
changes as opposed to drug or device 
treatment 
• Solidarity in primary prevention efforts will 
benefit both the individual and the society as 
a whole  
casinapioiv.va/content/dam/accademia/pdf/atherosclerosis.pdf 
Prophylaxis 1 
• Effective treatment reduces the first clinical 
manifestations of ASVD   
• The role of Governments is crucial   
• Aggregate risk factor reduction can decrease 
cardiovascular events by as much as 70% 
• Adequate Secondary prevention measures can 
reduce vascular event recurrence by 75% 
casinapioiv.va/content/dam/accademia/pdf/atherosclerosis.pdf 
Abbreviations  
• ACE - angiotensin-converting 
enzyme 
• ACS - acute coronary syndrome 
• ASCVD -arteriosclerotic 
cardiovascular disease 
• ASVD – atherosclerotic vascular 
disease 
• CKD - chronic kidney disease  
• CCTA - coronary computed 
tomography angiography  
• CT – computer tomography 
• CV - cardiovascular risk  
• CVD - cardiovascular disease 
 
 
• ICD - International Classification 
of Diseases 
• IGT - impaired glucose tolerance  
• HDL – high-density lipoprotein 
• LDL - low-density lipoprotein  
• MRA –  magnetic resonance 
angiogram 
• PAD –peripheral artery disease 
• SCORE - Systemic Coronary Risk 
Estimation 
• TG -triglycerides 
• VLDL - very low-density 
lipoprotein   
 
Diagnostic and treatment guidelines 
• Global Recommendations for the Management of 
Dyslipidemia 
• ESC/EAS Guidelines for the management of dyslipidemias 
• 2017 Focused update on Dual Antiplatelet Therapy (DAPT) 
• Joint 2016 European Guidelines on Cardiovascular Disease 
Prevention in Clinical Practice 
• Peripheral Arterial Diseases (Diagnosis and Treatment of)  
• 2013 ACC/AHA Guideline on the Treatment of Blood 
Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in 
Adults  
 
 
 
